Opening Hours: Sunday to Thursday – 7:30AM to  3:30PM 
Contact :0096265821618 

“This is what we stand for ”

About us

Overview

In the framework of Joint Arab action and in order to encourage the pharmaceutical industry, the Economic Unity Arab Council has adopted a decision on 6/3/1976 to establish an Arab institution that is capable of promoting this industry, which is the Arab Company for Drug Industries and Medical Appliances "ACDIMA", with a capital of (60) million Kuwaiti Dinars, that has been raised by the approval of the Extraordinary General Assembly held in Amman - Jordan on 10/10/2013 to (90) million Kuwaiti Dinars according to Riyadh Declaration for 2013, which approved the increase of the capital of joint Arab companies by at least 50%..

Chairman’s Letter

I am pleased, on behalf of my colleagues on the Board of Directors of the Arab Company for Pharmaceutical Industries and Medical Supplies - ACDIMA, to present to you the 47th annual report of the company.

This annual report includes the Board of Directors' report on the company's activities, the auditors' report, and the financial statements as of December 31, 2022, along with the notes related to the financial statements.

Acdima was established in 1976 at a time when the Arab pharmaceutical industry was either emerging in some countries or unavailable in others. Now, after 46 years since the company's founding, the pharmaceutical industry has developed in the majority of Arab countries, either with the support of ACDIMA or through self-investment. It is noteworthy that the world is witnessing radical transformations in business management in both public and private institutions to enhance their performance and ensure the sustainability of these entities.

From this standpoint, the Board of Directors aims during its current term to finalize a new vision supported by an effective strategic plan to achieve economic growth and provide a satisfactory return on investment for the company. One of the pillars of the plan will be the restructuring of the company's current operations based on sound governance and investment standards that align with global developments, ensuring appropriate growth in shareholders' equity and the sustainability of the company's operations.

In conclusion, I would like to express my sincere thanks and appreciation to our esteemed shareholders and Board members for their support, as well as my gratitude to Acdima's employees for their efforts in maintaining the company's operations. I also thank our subsidiary companies and all their personnel, as well as all relevant parties for their trust, continuous support, and dedicated efforts in making this leading Arab institution a success.

Khaled AlRabiah

Chairman of the Board

ACDIMA in Brief

As part of Arab joint action to encourage the pharmaceutical industry, the Arab Economic Unity Council made a decision to establish an Arab institution capable of fulfilling this mission

The Arab Company for Pharmaceutical Industries and Medical Supplies, "ACDIMA," was established on March 6, 1976, with an initial capital of 60 million Kuwaiti Dinars.

An increase in the capital of joint Arab companies by at least 50% was approved according to the Riyadh Declaration of 2013, and the paid-up capital amounts to 83,930,000 Kuwaiti Dinars

Objectives of the Company

General Objectives

  • Develop a national strategy for the pharmaceutical industry and its requirements.
  • Conduct economic and technical feasibility studies for the pharmaceutical industries in the Arab world.
  • Contribute to the financing and promotion of pharmaceutical industries in collaboration with all willing Arab countries.
  • Produce and market pharmaceutical raw materials, medical preparations, production supplies, devices, medical supplies, and packaging materials.
  • Train and develop competent personnel in the field of pharmaceutical industry and its requirements.

In the Field of Marketing

  • Import goods, intermediate materials, and production tools related to the company’s activities.
  • Market the company’s products and those of its subsidiaries within the Arab world and export any surplus.
  • Secure transportation means of and provide storage facilities and accompanying support services.
  • Own and register trademarks for the company’s products and achievements and manage them accordingly.

  

 

In the Field of Research

  • Conduct the necessary studies and scientific research to develop and improve existing practices.
  • Monitoring new developments in the pharmaceutical field, benefiting from them and publishing the results.

Internationally

  • ACDIMA has established relationships with multinational organizations to assist in setting up and participating in projects in the Arab world. It also focuses on training to build and develop qualified personnel for the pharmaceutical industry and medical supplies.

Mission

Ensuring optimal returns from investments that drive growth in the pharmaceutical industry sector in the Arab World 

Vision

To become the investment partner of choice for pharmaceutical industry in the Arab World

ACDIMA is a Share Holder in the following countries:

Board of Directors and Executive Management

Chairman of Board of Directors

His Exellency Khaled AlRabiah

Chairman of Board of Directors

Kingdom of Saudi Arabia
His Exellency Khaled AlRabiah
    • Chairman of  Arab Company for Drug Industries & Medical Appliances.
    • Representative of  Kingdom of Saudi Arabia
Members

Dr. Msaed El-Rezooqy

 Vice Chairman of Board of Directors

State of Kuwait

Dr. Ibrahim Al-Jafaly

Member of the Board

Kingdom of Saudi Arabia

Dr. Hammodi Abbas Hameed

Member of the Board

Republic of Iraq

Eng. Juma Diwan Al-Bahadli

Member of the Board 

Republic of Iraq

Mr . Youssef bin Mohammed bin Hajar

Member of the Board 

United Arab Emirates

Mr. Nasser Abdullah Al Attiyah

Member of the Board

State of Qatar

History

2013 - Present

 ACDIMA has increased its shares in many important companies.

2013

The capital has been increased by 50% to reach 90 million.

2006

ACDIMA owns 25% from CAD company 

2000

ACDIMA Center for Bioequivalence and Pharmaceutical Studies was established

1999

ACDIMA for Veterinary Medicines Industries “ACDIVET” was established, ACDIMA owns 100 %

1992

ACDIMA owns 64.14 % from Saiph Company 

1986

ACDIMA owns  20% from Spimaco Addawaeih's company 

1980

ACDIMA owns 9% from Julphar's Company 

1979

ACDIMA owns 34.06 % from ACAI's company 

1976-1998

 ِACDIMA has contributed to many important companies in the Arab world

1976

A Pan-Arab shareholding company established by a resolution from the Arab Economic Unity Council on March 6, 1976, Authorized Capital is: Kuwaiti Dinar (90) million.